# First-In-Man Study for an Ophthalmic Synthetic Tissue Substitute

> **NCT04037917** · NA · TERMINATED · sponsor: **CorNeat Vision Ltd.** · enrollment: 28 (actual)

## Conditions studied

- Glaucoma Eye
- Tissue Breakdown

## Interventions

- **DEVICE:** CorNeat EverPatch

## Key facts

- **NCT ID:** NCT04037917
- **Lead sponsor:** CorNeat Vision Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-12-11
- **Primary completion:** 2023-04-30
- **Final completion:** 2023-07-01
- **Target enrollment:** 28 (ACTUAL)
- **Why stopped:** Sponsor decision
- **Last updated:** 2023-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04037917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04037917, "First-In-Man Study for an Ophthalmic Synthetic Tissue Substitute". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04037917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*